INCATE

World Water Day: protecting Water, combating AMR Today, on World Water Day, we highlight the vital connection between clean water and antimicrobial resistance (AMR). - Antibiotic residues in wastewater can fuel resistance, allowing bacteria to adapt and survive - Hospital and agricultural runoff can spread resistant pathogens into natural water sources - Global water systems act as highways for AMR, making it a challenge that knows no borders To fight AMR, we must prioritize clean water, proper wastewater management, and responsible antibiotic use. A One Health approach, uniting human, animal, and environmental health, is key to safeguarding our future. At INCATE, we support innovators tackling AMR, because protecting water means protecting global health.

📢 Applications for the Interdisciplinary Course on Antibiotics and Resistance (ICARe) are now open! Antibiotic discovery and resistance are evolving rapidly, yet there’s a growing gap in hands-on experience and deep expertise in the field. ICARe aims to close this gap by bringing together top leaders from academia and industry with early-career scientists. Over 9 intensive days, participants will explore cutting-edge approaches to antibiotic discovery, resistance mechanisms, and their impact, through a combination of formal instruction and hands-on bioinformatics training. 🗓️ Application deadline: June 21, 2025 Info & application ➡️ https://lnkd.in/gUWX3-u

📢 Call on "Advances in Bacteriophage Research and Development with Therapeutic Applications" closing soon! Attention all #phage researchers, clinicians, and industry professionals! INCATE invites you to contribute to an exciting collection: Advances in Bacteriophage Research and Development with Therapeutic Applications. We are seeking groundbreaking manuscripts showcasing the transformative power of #phagetherapy. Whether you're pioneering bacteriophage-based treatments or harnessing phage-derived enzymes to combat infections, this is your opportunity to highlight your innovative work! Why bacteriophages? These natural bacterial predators are reshaping infection control by: - Targeting harmful bacteria with precision. - Offering safe, eco-friendly, and effective alternatives to fight antimicrobial resistance. - Harnessing the power of one of the most abundant organisms on Earth! Don’t miss your chance to contribute to this cutting-edge field. Learn more and submit here ➡️https://lnkd.in/eRJ2DqQ5

The rise of antimicrobial resistance (AMR) is often attributed to the overuse of antibiotics. However, researchers at the Indian Institute of Science (IISc) and Kiel University have uncovered another surprising factor: microbial interactions in soil. Their study reveals that a species of predatory bacteria can drive AMR development, even in the absence of antibiotic exposure. What does this mean for our understanding of AMR in natural environments beyond human influence? Read more here ➡️ https://lnkd.in/eFHc6tdC

The BEAM Alliance has released its 3rd BEAM Barometer on AMR, highlighting the ongoing challenges in financing innovation. While the 2024 results show some improvement over 2023, there's still a long road ahead. The key takeaway? SMEs continue to fight for survival, but they persist! Read the whole document here ➡️ https://lnkd.in/enQmrvgM

Celebrating 147 Years of Innovation – Congratulations, Shionogi & Co., Ltd! Today, we celebrate our industry partner, Shionogi, on its 147th anniversary! Founded in 1878 by Gisaburo Shiono in Osaka, Japan, Shionogi has grown from a small drug wholesaler into a leading global pharmaceutical company. With a legacy of medical innovation and a commitment to addressing unmet medical needs, Shionogi continues to make a profound impact on healthcare worldwide. We are grateful for your support and dedication. Your contribution to INCATE enables us to support early-stage AMR innovators, driving progress in the fight against antimicrobial resistance. Congratulations, Shionogi! Here's to many more years of success and innovation! 

People have long linked antibiotic resistance to patient behavior, such as not taking antibiotics as directed. But what if other factors play a role, like microplastics? Could bacteria exposed to microplastics develop resistance to multiple commonly used antibiotics? Find out more here ➡️ https://lnkd.in/gZP5cHyH

In 2022, Shionogi & Co., Ltd and Global Antibiotic R&D Partnership (GARDP) made history by signing the first-ever voluntary license agreement for an antibiotic. Two years on, where do things stand? If you you like to know more about it - explore the progress, the challenges and key lessons learned from this partnership - join GARDP’s upcoming webinar. Speakers: - Monika Schneider, Ph.D. – Shionogi Inc. (U.S.) - Rahul Dwivedi – Global Antibiotic R&D Partnership (GARDP) - Melynda Watkins – Clinton Health Access Initiative, Inc. - Manish Dhanuka – Orchid Pharma Moderator: - Peter Beyer – Deputy Executive Director, Global Antibiotic R&D Partnership (GARDP) 📅 March 28, 2025 | 3pm – 4.15pm CET Don't miss this insightful discussion: register now! ➡️ https://lnkd.in/gS9CMJTV

Every time antimicrobial resistance (AMR) is mentioned we speak about how slowly it is to develop new antibiotics, how costly, and how empty the pipeline is regarding the development of new antimicrobial drugs. But what if we could prolong the effectiveness of the medicines we already have? Curious? Read this Minimising AMR article and let us know your thoughts ➡️ https://lnkd.in/eUq_tsRY

💥 Our March Newsletter is out! 💥 - Highlights of the 9th AMR Conference - Funding opportunities 🚀 ...and more! Read all about it in INCATE's Newsletter ➡https://lnkd.in/eJUf9N5a Haven't you subscribed yet? Don't fall behind, subscribe here ➡https://lnkd.in/eJ7vyBCa